[Immunotherapy using P. aeruginosa: type III secretion system-based live bacterial vector].
Epaulard
O
O
Equipe BacVac, Laboratoire de Thérapeutiques Recombinantes Expérimentales, TIMC-IMAG UMR CNRS 5525, Université Joseph Fourier, Grenoble, France.
Derouazi
M
M
Pelletier
L
L
Polack
B
B
Toussaint
B
B
D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009894:Opportunistic Infections / Q000276:immunology / Q000382:microbiology; D011552:Pseudomonas Infections / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D014774:Virulence